Avoro Capital Advisors LLC

Position in QURE — uniQure N.V.

CIK 1633313 NEW YORK, NY

Position in QURE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$97,439,378

-$49,730,122 QoQ

Shares Held

5,959,595

-3.1% QoQ

Ownership

9.45%

of shares outstanding

% of Portfolio

0.96%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Avoro Capital Advisors LLC holds $8,549,473,651 across 28 Biotechnology names. QURE ranks #18 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ASND	Ascendis Pharma A/S	5,062,500	$1,157,945,625
2	MDGL	Madrigal Pharmaceuticals, Inc.	1,818,181	$951,763,208
3	KRYS	Krystal Biotech, Inc.	2,888,888	$746,257,548
4	ARGX	Argenx SE	1,000,000	$730,250,000
5	ARWR	Arrowhead Pharmaceuticals, Inc.	10,699,999	$670,889,937
6	KYMR	Kymera Therapeutics, Inc.	7,474,747	$622,571,677
7	APLS	Apellis Pharmaceuticals, Inc.	12,222,222	$491,699,991
8	CNTA	Centessa Pharmaceuticals plc	11,430,455	$454,017,672

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$97,439,378	5,959,595	-3.1%	Shares	Sole	2026-05-15
2025-12-31	$147,169,500	6,150,000	0.0%	Shares	Sole	2026-02-17
2025-12-31	$147,169,500	6,150,000	+38.4%	Shares	Sole	2026-03-16
2025-09-30	$259,422,196	4,444,444	+22.6%	Shares	Sole	2025-11-14
2025-06-30	$50,532,500	3,625,000	+66.7%	Shares	Sole	2025-08-14
2025-03-31	$23,055,000	2,175,000	0.0%	Shares	Sole	2025-05-15
2024-12-31	$38,410,500	2,175,000	+24.3%	Shares	Sole	2025-02-14
2020-09-30	$64,452,500	1,750,000	+16.7%	Shares	Sole	2020-11-16
2020-06-30	$67,590,000	1,500,000	-9.1%	Shares	Sole	2020-08-14
2020-03-31	$78,292,500	1,650,000	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.